LunarCrush LLM | post/tweet::1945613389704958300

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4969 followers
Created: 2025-07-16 22:35:54 UTC

🦉 Amgen’s maridebart cafraglutide cut weight by up to XX% in patients without diabetes and XX% in those with T2D, outperforming placebo by X to 13x. No plateau by week XX suggests ongoing efficacy. 
$AMGN $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS
#GLP1 #GIP #Obesity


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945613389704958300/c:line.svg)

**Related Topics**
[gibraltar pound](/topic/gibraltar-pound)
[hims](/topic/hims)
[pfe](/topic/pfe)
[manat](/topic/manat)
[amgn](/topic/amgn)
[$hims](/topic/$hims)
[$vani](/topic/$vani)
[$zldpf](/topic/$zldpf)

[Post Link](https://x.com/AponiaAnalytics/status/1945613389704958300)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

aponia_analytics @AponiaAnalytics on x 4969 followers Created: 2025-07-16 22:35:54 UTC

🦉 Amgen’s maridebart cafraglutide cut weight by up to XX% in patients without diabetes and XX% in those with T2D, outperforming placebo by X to 13x. No plateau by week XX suggests ongoing efficacy. $AMGN $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #GLP1 #GIP #Obesity

XXX engagements

Engagements Line Chart

Related Topics gibraltar pound hims pfe manat amgn $hims $vani $zldpf

Post Link